Skip to content
ES
MARKETS / NASDAQ / ADUS
NASDAQ · SERVICES-HOME HEALTH CARE SERVICES · LARGE CAP

Addus HomeCare Corp. ADUS

17 fiscal years on record · USD · FY2025 reported · SEC filings only
$1.4B
▲ 23.2% YoY
$95.9M
▲ 30.3% YoY
$103.8M
▼ 6.0% YoY
In brief

What this company does

Addus has been providing home care services since 1979. As of December 31, 2025, it provided services in 23 states through approximately 262 offices. For the year ended December 31, 2025, it served approximately 107,000 discrete consumers. One payor client, the Illinois Department on Aging, accounted for 18.1% of its net service revenues in 2025, primarily within its personal care segment. It operates three segments: personal care, hospice, and home health. Its personal care segment provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. Its hospice segment provides physical, emotional and spiritual care for people who are terminally ill, as well as related services for their families. Its home health segment provides services that are primarily medical in nature, including skilled nursing and physical, occupational and speech therapy, to individuals who may require assistance during an illness or after hospitalization.

Written from the business description in Addus HomeCare Corp's annual report to the U.S. Securities and Exchange Commission, filed 24 February 2026. Every sentence was checked against that document before publication.

Growth
USD 1.4B
Revenue, FY2025 · full 17-year series below
Revenue $B Net income $B
FY2025 · Revenue 1.4 · Net income 0.1
0.5B1.0B200920112013201520172019202120232025
Compound annual growth
+14.4%
+13.2%
+15.5%
+12.9%
+27.7%
+23.7%
+23.5%
+20.3%
+22.5%
+20.2%
+17.5%
+15.9%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +13.2% a year over five years — but profit grew faster: net income at +23.7%, earnings per share at +20.2%.

The share count rose from 0.02B to 0.02B over the period.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
7 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 9.7% · Net 6.7%
5%200920112013201520172019202120232025
ROE
FY2025 · ROE 9.3%
5%10%15%-1%-2%200920112013201520172019202120232025
Gross margin32.5%
Operating margin9.7%
Net margin6.7%
Return on assets6.7%
EBITDAUSD 155.0M

Each USD of equity produced 9 cents of profit this year.

Cash & shareholders
—
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 103.8
40M80M200920112013201520172019202120232025
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—

Total assetsUSD 1.4B
EquityUSD 1.1B
Gross debtUSD 121.0M
Current ratio1.80×

Equity funds 76% of total assets.

The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B1.41.21.11.00.90.80.60.50.40.40.30.30.30.20.20.20.3
Operating income $B0.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.0
EBITDA $B0.20.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.0
Income tax $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Net income $B0.10.10.10.00.00.00.00.00.00.00.00.00.00.0−0.00.00.0
Free cash flow $B0.10.10.10.10.00.10.00.00.0−0.00.00.00.00.00.00.0−0.0
EPS, diluted $5.224.233.832.842.812.081.771.331.031.071.041.101.730.71−0.180.57−0.66
Dividend / sh $·················
Payout %·················
ROE %9.38.89.37.68.36.76.87.57.48.28.710.218.48.4−2.36.8·
Shares out B0.020.020.020.020.020.020.020.010.010.010.010.010.010.010.010.01·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 83 reconciliationsAUDITED

Reconciled in 17 of 19 fiscal years. 12 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Home Health Care Services
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2009

Share this section

Download image